Mesoblast Updates On Rexlemestrocel-L Program In Chronic Low Back Pain

… Limited (NASDAQ: MESO) provided an update on the strategy for bringing rexlemestrocel-L to patients in the U.S. with chronic low back pain (CLBP) …
Source: back pain